Sure seems to me that there are 100's of big name companies investing many millions in the stem cell revolution :$! Glad I'm invested in the most undervalued one right now. :$ USRM <<-------- stock of 2017
Dr. Landow, has been involved in Healthcare for almost 30 years and he is currently the Managing Director of Advanced Stem Cell Rx, which is building the largest network of autologous stem cell treatment centers in the US.
Dr. Landow first became engaged as a healthcare consultant over 20 years ago, and has worked with several of the largest and nationally prominent Health Systems along with numerous Wall Street firms and advising on medical-industry acquisitions, IPO’s and recapitalizations involving biotechnology, bio-medical devices and healthcare service companies.
In 1994 he founded New York Medical, Inc. (”NYM”), one of the pioneering practice management companies. NYM quickly established itself as one of the region’s leading specialty practice management entities, offering extensive vertical integration and turnkey solutions. and encompassed the following specialties: neurology, spine and orthopedic surgery, pain management, physiatry, physical & occupational therapy, acupuncture, and internal medicine.
He has served on the Medical advisory board for the Juvenile Diabetes Foundation and the development board of The Feinstein Institute for Medical Research, which is the research branch of the Northwell Health. Dr. Landow earned his B.A. in Economics at Vassar College in New York, subsequently completing an M.S. in Nutrition and Biochemistry at Columbia University in New York. He earned his M.D. at the University of Miami, School of Medicine.